Viscosin is an acidic antibiotic first isolated from the culture fluid of Pseudomonas viscosa by Kochi,3) which was reported to be active to tubercle bacillus and certain viruses.4) Ohno and his coworkers5) proposed the structure (Ia) as a peptidolipid containing 3-hydroxy acid at the N-terminus of hexapeptide.
Hitomi, et al.6) have prepared several analogs of Ia, acyl-L-leucyl-glycyl-L-seryl-D-valyl-Lthreonyl-L-leucine (acyl: hexanoyl, octanoyl, decanoyl, myristoyl, palmitoyl and stearoyl) of minimum inhibitory concentration.
Furthermore, the fact that some naturally occurring depsipeptides such as fortuitine,7) esperine,8) surfactin9) and the peptidolipids from Mycobacterium johnei and Nocardia asteroides10) have been isolated only as a mixture with closely related compounds, usually with a few kinds of acyl homologs, suggests possible heterogeneity of viscosin preparation. In addition, no clear evidence for D-configuration of valine in viscosin molecule has been presented up to date. Ambiguities on the proposed structure (Ia) for viscosin arising from the above points prompted us to undertake synthetic study of a group of 3-hydroxyacylhexapeptides including Ia, b and their stereoisomers (IIa, b).
We found it convenient for our purpose to use L-or D-3-hydroxyacyl-L-leucine hydrazides (IX or X) as synthetic intermediates, since the optically active compounds could be easily obtained from their diastereoisomeric mixtures (VIII) by fractional crystallization and directly utilized for the subsequent peptide coupling reaction via the azides.
The present communication concerns the synthesis of these hydrazides IX and X. The synthetic routes are outlined in Chart 1.
The intermediates, DL-3-hydroxyacyl-L-leucine methyl esters (VII) were prepared by the following two routes. Reformatsky reaction11) or sodium borohydride reduction of the corresponding 3-keto acid ester, was converted to the hydrazide (IV) ( Table I) , which was coupled with L-leucine methyl ester by means of the azide method to give oily product (VII). (ii) III was saponified to the corresponding free acid (V), which was converted into the N-hydroxysuccinimide ester (VI)12) (Table III) , and VI was coupled with L-leucine methyl ester to yield VII.
VII was then converted, without purification, into the corresponding hydrazide, DL-3-hydroxyacyl-L-leucine hydrazide (VIII). The resolution of VIII into the optically active diastereoisomers (IX and X) could be readily accomplished by fractional crystallization using alcohols such as MeOH (for VIIIb-g), EtOH (for VIIIh-j) or iso-PrOH (for Villa). In order to assess optical purity of the products thus obtained , IXb-d, f, h and Xb-dd, f, h were also synthesized by another route . Optically active 3-hydroxy fatty acids were prepared by the cinchonidine13) or ephedrine resolution of the respective racemic acids (Vb-d, f, h) (Table II) and then converted to the corresponding N-hydroxysuccinimide esters (VI' and VI") (Table III) , which were then reacted with L-leucine methyl ester followed by hydrazinolysis to afford IXb-d, f, h and Xb-d, f, h respectively . The preparations of each compound obtained by the two routes were identical in mp and optical rotation. From these data, it is quite probable that the fractional crystallization of the diastereoisomeric mixture (VIII) described above gave satisfactory results.
The yields, physical constants and elemental analyses of the synthesized N-acyl-L-Ieucine hydrazides are given in Table IV and V.
The antibacterial activities of DL-3-hydroxy fatty acids (V), their hydrazides (IV), and D-and L-3-hydroxyacyl-L-leucine hydrazides (IX and X) were examined with four kinds of microorganisms, and the activities were compared with those of saturated n-fatty acids. As shown in Table VI , most of the synthesized compounds exhibited antimicrobial activities only comparable to or less than those of the saturated n-fatty acids of the corresponding carbon numbers against any of the microorganisms tested.
DL-3-Hydroxy Fatty Acid Hydrazides (IVa-j) ( Table I) a) DL-3-Hydroxy Fatty Acid Ethyl Esters (IIIa-j):
IIIa-h were prepared according to the literature,11) and IIIi and IIIj were obtained by NaBH4 reduction of the corresponding 3-oxo fatty acid esters as follows: to a solution of ethyl 3-oxooctadecanoate15) (9.8g, 0.03 mole) in EtOH (400ml) was added dropwise NaBH4 (0.015 mole) in H2O (12ml) with vicorous added to the reaction mixture, and the solution was allowed to stand at room temperature for 1 hr . The reaction mixture was then poured into H2O (60ml), which was evaporated in vacuo to dryness . The resulting solid residue was extracted with ether (500ml).
The extract was washed successively with H2O, 5% HCl and H2O, dried over MgSO4 and evaporated in vacuo to yield a crystalline residue , which was recrystalSimilarly, from ethyl 3-oxohexadecanoate15) (8.9g, 0.03 mole), was obtained ethyl DL-3-hydroxyhexadecanoate (IIIi) as an oily product:
Yield 5.5g (62%). All the esters thus obtained were used without further purification . b) DL-3-Hydroxy Fatty Acid Hydrazides (IVa-j): To a solution of III (0 .05 mole) in EtOH was added hydrazine hydrate (0.2 mole) and the reaction mixture was refluxed for 2 hr. After cooling, the resulting crystal was collected by filtration and recrystallized from suitable solvent shown in Table I (DCC) (0.05 mole). The mixture was stirred at room temperature for 2 hr and allowed to stand overnight in a refrigerator. After AcOH (0.6ml) was added, the mixture was stirred for 20min. N, N'-Dicyclohexylurea was removed by filtration and washed with AcOEt.
The combined filtrate and washings were washed successively with H2O, 5% NaHCO3 and H2O, and dried over MgSO4. The solvent was evaporated in vacuo to yield a crystalline residue.
Recrystallization from AcOEt with petr. ether yielded product (VI).
In a similar manner, VI' and VI" were prepared from V' and V", respectively (Table III) .
DL-3-Hydroxyacyl-L-leucine Hydrazides (VIIIa-j)-a) DL-3-Hydroxyacyl-L-leucine Methyl Esters (VIIa-j):
i) From IV: To a solution of IV (0.023 mole) dissolved in a mixture of glac. AcOH (70ml) stirred for 10min, diluted with ice-water (100ml) and extracted with cold AcOEt (250ml). The AcOEt extract was washed successively with ice-cooled saturated NaCl solution, 1 N NaHCO3 and H2O, and dried overnight in a refrigerator and for additional 2 days at room temperature.
The reaction mixture was washed successively with 1 N HCl, 1 N NaHCO3 and H2O, dried over MgSO4 and evaporated in vacuo to give oily product (VII) in 69-80% yields. ii) From VI:
A solution of VI (0.017 mole) and L-leucine methyl ester (0.017 mole) in AcOEt (30ml) was stirred at room temperature for 3 hr and allowed to stand for additional 16 hr. The subsequent purification procedure was the same as described in i). Yields of the oily products, 83-99%.
To a solution of VII (0.023 mole) in MeOH (60ml) was added hydrazine hydrate (5.5ml) and the reaction mixture was allowed to stand overnight at room temperature.
The solvent was evaporated in vacuo, and H2O (50ml) was added to the residue. After cooling, the resulting crystal was collected by filtration, washed with H2O and dried over P2O5 in vacuo. Yields were in a range of 57-88%
(from IV or VI). Resolution of VIIIa-j VIII was dissolved in an appropriate alcohol shown in Table IV and the solution was kept overnight in a refrigerator.
The crystals thus formed were collected by filtration and recrystallized three times from the same solvent used above to give L-3-hydroxyacyl-L-leucine hydrazide (IX) as colorless needles (Table IV) . The mother liquor was concentrated to dryness under reduced pressure to give a solid residue which was dissolved in a small amount of the same alcohol as above, and then the solution concentrated in vacuo to give a solid material.
After the same procedure was repeated once again, the material was further reprecipitated twice from suitable solvent shown in Table V to yield D-3-hydroxyacyl-Lleucine hydrazide (X) as colorless powder (Table V) .
D-or L-3-Hydroxyacyl-L-leucine Hydrazides (IX or X) from VI' or VI Using essentially the same procedure as described for the synthesis of VIII [method a)-ii)], the ester (VI' or VI'') of the optically active acid was allowed to react with L-leucine methyl ester and the resulting product was hydrazinolyzed to give IX or X (Table IV and V) . Antibacterial Test (Table VI) The minimum amount of a compound necessary for complete inhibiton of bacterial growth was determined by a standard two fold tube dilution method using a bouillon agar (in E. coli, or St. aureus), 1% glucose added-bouillon (in Candida albicans) and 10% albumin added-Dubos media (in Mycobact. tuberculosis).
